# Allogeneic Micronized Amniotic Membrane Product for the Treatment of Hidradenitis Suppurativa

> **NCT04541550** · PHASE1 · WITHDRAWN · sponsor: **IntegoGen, LLC**

## Conditions studied

- Hidradenitis Suppurativa

## Interventions

- **DRUG:** AMP-001 Low Dose
- **DRUG:** AMP-001 Medium Dose
- **DRUG:** AMP-001 High Dose

## Key facts

- **NCT ID:** NCT04541550
- **Lead sponsor:** IntegoGen, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-04-01
- **Primary completion:** 2021-07-01
- **Final completion:** 2021-07-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study didn't proceed to FDA submission
- **Last updated:** 2021-09-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04541550

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04541550, "Allogeneic Micronized Amniotic Membrane Product for the Treatment of Hidradenitis Suppurativa". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT04541550. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*